ENX-102 is a highly specific GABA A α 2,3,5-positive allosteric modulator that is in development for the treatment of generalized anxiety disorder (GAD). Based on robust preclinical data and a ...

Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces the initiation of scale-up and manufacturing of toxicology batches for SAN2219, advancing the program toward clinical ...